Introducing the One IPO Roadmap

The IPO has released the first roadmap for its new One IPO service as it moves closer to public launch. Currently in private beta, the service already offers improvements such as near real-time patent updates, but the IPO acknowledges significant work remains.

The roadmap outlines three phases: before launch, focused on essential fixes and internal efficiency upgrades; launch window (the first six months), where customer‑requested improvements will be prioritised; and beyond launch, covering longer‑term enhancements over months 6–12.

Described as Roadmap 1.0, it will be regularly updated as priorities evolve. The IPO emphasises that improvements will continue for years, and absence from the current roadmap doesn’t rule out future changes.

19 replies

Trackbacks & Pingbacks

  1. bronchitis treatment

    bronchitis treatment

  2. secure online health purchases

    secure online health purchases

  3. insurance coverage information

    insurance coverage information

  4. minoxidil foam vs liquid evidence‑based guide

    minoxidil foam vs liquid evidence‑based guide

  5. minoxidil 2% vs 5% shedding

    minoxidil 2% vs 5% shedding

  6. minoxidil regrowth science

    minoxidil regrowth science

  7. ivermectin scabies therapy

    ivermectin scabies therapy

  8. toradol peak effect

    toradol peak effect

  9. generic liraglutide reddit

    generic liraglutide reddit

  10. minoxidil foam costco

    minoxidil foam costco

  11. rifaximin metronidazole combination

    rifaximin metronidazole combination

  12. metronidazole 400mg for bv dosage

    metronidazole 400mg for bv dosage

  13. proscar drug group

    proscar drug group

  14. semaglutid i mat

    semaglutid i mat

  15. dutasteride precio

    dutasteride precio

  16. avanafil tablets 100mg price

    avanafil tablets 100mg price

  17. cyclosporine psoriasis cost

    cyclosporine psoriasis cost

  18. sildenafil bph dosing

    sildenafil bph dosing

  19. voriconazole dose oral

    voriconazole dose oral

Comments are closed.